Diamyd Medical provides update on ongoing Activities

Diamyd Medical today announced that it, as part of an ongoing strategic review, has received several proposals from external parties, including formal non-binding Letters of Intent, as well as invitations to invest into various business opportunities. Whilst implementing several cost reduction steps, the Company is structuring its approach for evaluating these opportunities with the aim to maximize value for its shareholders. “Considering the shock with the yet unexplained failure of our Phase-3 study with retogatein, which brought a dramatic fall in the Company’s share value, times are